Cargando…
Incidence of metabolic syndrome in breast cancer survivors on adjuvant hormonal therapy
Autores principales: | Kate, Anahita, Kadambari, Dharanipragada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831487/ https://www.ncbi.nlm.nih.gov/pubmed/27127393 http://dx.doi.org/10.4103/0976-500X.179362 |
Ejemplares similares
-
Polymorphisms of T- cell leukemia 1A gene loci are not related to the development of adjuvant letrozole-induced adverse events in breast cancer
por: Umamaheswaran, Gurusamy, et al.
Publicado: (2021) -
Dosimetric comparison between interstitial brachytherapy and volumetric-modulated arc therapy for tumor bed boost in breast cancer
por: Periasamy, Kannan, et al.
Publicado: (2021) -
Low serum 25-hydroxy vitamin D levels are associated with aggressive breast cancer variants and poor prognostic factors in patients with breast carcinoma
por: Karthikayan, Arunkumar, et al.
Publicado: (2018) -
Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer [Letter]
por: Bekele, Firomsa
Publicado: (2021) -
Precise pancreatic necrosectomy by step-up approach
por: Sundaramurthi, Sudharsanan, et al.
Publicado: (2021)